<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">nefr</journal-id><journal-title-group><journal-title xml:lang="ru">Нефрология</journal-title><trans-title-group xml:lang="en"><trans-title>Nephrology (Saint-Petersburg)</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1561-6274</issn><issn pub-type="epub">2541-9439</issn><publisher><publisher-name>Pavlov First Saint-Petersburg State Medical University</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.24884/1561-6274-2006-10-3-14-22</article-id><article-id custom-type="elpub" pub-id-type="custom">nefr-594</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОБЗОРЫ И ЛЕКЦИИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>REVIEWS AND LECTURES</subject></subj-group></article-categories><title-group><article-title>МЕТАБОЛИТЫ АРАХИДОНОВОЙ КИСЛОТЫ – ДЕТЕРМИНАНТЫ ПАРЕНХИМАТОЗНО-СТРОМАЛЬНЫХ ОТНОШЕНИЙ В ПОЧКАХ В НОРМЕ И ПРИ ПАТОЛОГИИ</article-title><trans-title-group xml:lang="en"><trans-title>METABOLITES OF ARACHIDONIC ACID – DETERMINANTS OF PARENCHYMA-STROMA RELATIONS IN THE KIDNEYS IN HEALTH AND DISEASE</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Баринов</surname><given-names>Э. Ф.</given-names></name><name name-style="western" xml:lang="en"><surname>Barinov</surname><given-names>E. F.</given-names></name></name-alternatives><bio xml:lang="ru"><p>кафедра гистологии, цитологии и эмбриологии</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Сулаева</surname><given-names>О. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Sulaeva</surname><given-names>O. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>кафедра гистологии, цитологии и эмбриологии</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Лам</surname><given-names>М. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Lam</surname><given-names>M. M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>кафедра гистологии, цитологии и эмбриологии</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff xml:lang="ru" id="aff-1"><institution>Донецкий государственный медицинский университет им. М. Горького, г. Донецк</institution><country>Ukraine</country></aff><pub-date pub-type="collection"><year>2006</year></pub-date><pub-date pub-type="epub"><day>10</day><month>03</month><year>2006</year></pub-date><volume>10</volume><issue>3</issue><fpage>14</fpage><lpage>22</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Баринов Э.Ф., Сулаева О.Н., Лам М.М., 2006</copyright-statement><copyright-year>2006</copyright-year><copyright-holder xml:lang="ru">Баринов Э.Ф., Сулаева О.Н., Лам М.М.</copyright-holder><copyright-holder xml:lang="en">Barinov E.F., Sulaeva O.N., Lam M.M.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://journal.nephrolog.ru/jour/article/view/594">https://journal.nephrolog.ru/jour/article/view/594</self-uri><abstract><p>.</p></abstract><trans-abstract xml:lang="en"><p>.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>почка</kwd><kwd>метаболиты арахидоновой кислоты</kwd></kwd-group><kwd-group xml:lang="en"><kwd>kidney</kwd><kwd>metabolites of arachidonic acid</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Данн МДж (ред.). Почечная эндокринология. Медицина, М., 1987; 11-111</mixed-citation><mixed-citation xml:lang="en">Данн МДж (ред.). Почечная эндокринология. Медицина, М., 1987; 11-111</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Campean V, Theilig F, Paliege A et al. Key enzymes for renal prostaglandin synthesis: site specific expression in rodent kidney (rat, mouse). Am J Physiol Renal Physiol 2003; 285: F19-F32</mixed-citation><mixed-citation xml:lang="en">Campean V, Theilig F, Paliege A et al. Key enzymes for renal prostaglandin synthesis: site specific expression in rodent kidney (rat, mouse). Am J Physiol Renal Physiol 2003; 285: F19-F32</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Karnik AM, Bashir R, Khan FA. Renal involvement in the systemic inflammatory reaction syndrome. Renal Fail 1998; 20: 103-116</mixed-citation><mixed-citation xml:lang="en">Karnik AM, Bashir R, Khan FA. Renal involvement in the systemic inflammatory reaction syndrome. Renal Fail 1998; 20: 103-116</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">McGiff JC, Ferreri NR, Carroll MA. The eicosanoid factor: a determinant of individuality of nephron segment. J Physiol Pharmacol 2002; 53 (4): 525-532</mixed-citation><mixed-citation xml:lang="en">McGiff JC, Ferreri NR, Carroll MA. The eicosanoid factor: a determinant of individuality of nephron segment. J Physiol Pharmacol 2002; 53 (4): 525-532</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Reinhold SW, Vitzthum H, Filbeck T et al. Gene expression of 5-, 12- and 15-lipoxygenases and leukotriene receptors along the rat nephron. Am J Physiol Renal Physiol 2005; 289 (6): F1138-F1143</mixed-citation><mixed-citation xml:lang="en">Reinhold SW, Vitzthum H, Filbeck T et al. Gene expression of 5-, 12- and 15-lipoxygenases and leukotriene receptors along the rat nephron. Am J Physiol Renal Physiol 2005; 289 (6): F1138-F1143</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Fitzpatrick FA, Soberman RJ. Regulates formation of eicosanoids. J Clin Invest 2001; 277: 1347-1351</mixed-citation><mixed-citation xml:lang="en">Fitzpatrick FA, Soberman RJ. Regulates formation of eicosanoids. J Clin Invest 2001; 277: 1347-1351</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Piro M, Giubilato G, Pinelli M. Endothelium and inflammation. Panminerva Med 2005; 47 (2): 75-80</mixed-citation><mixed-citation xml:lang="en">Piro M, Giubilato G, Pinelli M. Endothelium and inflammation. Panminerva Med 2005; 47 (2): 75-80</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Han WK, Sapirestein A, Hung CC et al. Cross-talk between cytosolic phospholipase A2 (cPLA2) alpha and secretory PLA2 (sPLA2) in hydregen peroxide-induced arachidonic acid release in murine mesangial cells. J Biol Chem 2003; 278 (26): 24153-42163</mixed-citation><mixed-citation xml:lang="en">Han WK, Sapirestein A, Hung CC et al. Cross-talk between cytosolic phospholipase A2 (cPLA2) alpha and secretory PLA2 (sPLA2) in hydregen peroxide-induced arachidonic acid release in murine mesangial cells. J Biol Chem 2003; 278 (26): 24153-42163</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Nasrallah R, Landry A, Scholey JW et al. Characterisation of the prostaglandine synthesis in cultured mesangial cells. Prostaglandins Leukot Essent Fatty Acids 2004; 70 (5): 455-464</mixed-citation><mixed-citation xml:lang="en">Nasrallah R, Landry A, Scholey JW et al. Characterisation of the prostaglandine synthesis in cultured mesangial cells. Prostaglandins Leukot Essent Fatty Acids 2004; 70 (5): 455-464</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Kantarki A, Thomas EVD. Lipoxins in chronic inflammation. Crit Rev Oral Biol Med 2003; 14 (1): 4-12</mixed-citation><mixed-citation xml:lang="en">Kantarki A, Thomas EVD. Lipoxins in chronic inflammation. Crit Rev Oral Biol Med 2003; 14 (1): 4-12</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Natarajan R, Reddy MA. HETEs and EETs in renal glomerular and epithelial cell function. Curr Opin Pharmacol 2003; 3 (2): 198-203</mixed-citation><mixed-citation xml:lang="en">Natarajan R, Reddy MA. HETEs and EETs in renal glomerular and epithelial cell function. Curr Opin Pharmacol 2003; 3 (2): 198-203</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Castrop H, Schweda F, Schumacher K et al. Role of renocortical cyclooxygenase-2 for renal vascular resistance and macula densa control of renin secretion. J Am Soc Nephrol 2001; 12: 867-874</mixed-citation><mixed-citation xml:lang="en">Castrop H, Schweda F, Schumacher K et al. Role of renocortical cyclooxygenase-2 for renal vascular resistance and macula densa control of renin secretion. J Am Soc Nephrol 2001; 12: 867-874</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Kriz W, LeHir M. Pathways to nephron loss starting from glomerular diseases – insights from animal model. Kidney Int 2005; 67 (2): 404-419</mixed-citation><mixed-citation xml:lang="en">Kriz W, LeHir M. Pathways to nephron loss starting from glomerular diseases – insights from animal model. Kidney Int 2005; 67 (2): 404-419</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Patrignani P, Tacconelli S, Sciulli MG, Capone ML. New insights into COX-2 biology and inhibition Brain Res Brain Res Rev 2005; 48 (2): 352-359</mixed-citation><mixed-citation xml:lang="en">Patrignani P, Tacconelli S, Sciulli MG, Capone ML. New insights into COX-2 biology and inhibition Brain Res Brain Res Rev 2005; 48 (2): 352-359</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Vitzthum H, Abt I, Einhellig S. Gene expression of prostanoid forming enzymes along the rat nephron. Kidney Int 2002; 62: 1570-1581</mixed-citation><mixed-citation xml:lang="en">Vitzthum H, Abt I, Einhellig S. Gene expression of prostanoid forming enzymes along the rat nephron. Kidney Int 2002; 62: 1570-1581</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Harris RC, Breyer MD. Physiological regulation of COX-2 in the kidney. Am J Renal Physiol 2001; 281: F1-F11</mixed-citation><mixed-citation xml:lang="en">Harris RC, Breyer MD. Physiological regulation of COX-2 in the kidney. Am J Renal Physiol 2001; 281: F1-F11</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Harris RC. Cyclooxygenase-2 in the kidney. J Am Soc Nephrol 2000; 11: 2387-2394</mixed-citation><mixed-citation xml:lang="en">Harris RC. Cyclooxygenase-2 in the kidney. J Am Soc Nephrol 2000; 11: 2387-2394</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Schermann J. Cyclooxygenase-2 and macula densa control of renin secretion. Nephrol Dial Transplant 2001; 16: 1735-1738</mixed-citation><mixed-citation xml:lang="en">Schermann J. Cyclooxygenase-2 and macula densa control of renin secretion. Nephrol Dial Transplant 2001; 16: 1735-1738</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Petry C, Fritz G, Pfeilschifter J. Inhibition of Rho modulates cytokine induced prostaglandin E2 formation in renal mesangial cells. Biochim Biophys Acta 2004; 1636 (2-3): 108-118</mixed-citation><mixed-citation xml:lang="en">Petry C, Fritz G, Pfeilschifter J. Inhibition of Rho modulates cytokine induced prostaglandin E2 formation in renal mesangial cells. Biochim Biophys Acta 2004; 1636 (2-3): 108-118</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Favreau F, Petit-Рaris I, Hauet T. Cyclooxygenase 1-dependent production of F2-isoprostane and changes in redox status during warm renal ishemia-reperfusion. Free Radic Biol Med 2004; 36 (8): 1034-1042</mixed-citation><mixed-citation xml:lang="en">Favreau F, Petit-Рaris I, Hauet T. Cyclooxygenase 1-dependent production of F2-isoprostane and changes in redox status during warm renal ishemia-reperfusion. Free Radic Biol Med 2004; 36 (8): 1034-1042</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Nasrallah R, Hebert RL. Prostacyclin signaling in the kidney: implications for health and desease. Am J Physiol Renal Physiol 2005; 289 (2): F235-246</mixed-citation><mixed-citation xml:lang="en">Nasrallah R, Hebert RL. Prostacyclin signaling in the kidney: implications for health and desease. Am J Physiol Renal Physiol 2005; 289 (2): F235-246</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Jansen BL, Stubbe J, Hansen PB. Localization of prostaglandin E2 receptors in the rat kidney Am J Physiol Renal Physiol 2001; 280: F1001-1009</mixed-citation><mixed-citation xml:lang="en">Jansen BL, Stubbe J, Hansen PB. Localization of prostaglandin E2 receptors in the rat kidney Am J Physiol Renal Physiol 2001; 280: F1001-1009</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Lemieux LI, Rahal SS, Kennedy CR. PGE2 reduces arachidonic acid release in murine podocytes: evidence for autocrine feedback loop. Am J Physiol Renal Physiol 2003; 284 (2): 302-309</mixed-citation><mixed-citation xml:lang="en">Lemieux LI, Rahal SS, Kennedy CR. PGE2 reduces arachidonic acid release in murine podocytes: evidence for autocrine feedback loop. Am J Physiol Renal Physiol 2003; 284 (2): 302-309</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Undurti ND. Is angiotensin II an endogenous pro-inflammatory molecule? Med Sci Monit 2005; 11 (5): R155-162</mixed-citation><mixed-citation xml:lang="en">Undurti ND. Is angiotensin II an endogenous pro-inflammatory molecule? Med Sci Monit 2005; 11 (5): R155-162</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Masaru M, Rich KA, Ingram M et al. Nitric oxide, anti-inflammatory drugs on renal prostaglandins and cyclooxygenase-2. Hypertension 2002; 39: 785-789</mixed-citation><mixed-citation xml:lang="en">Masaru M, Rich KA, Ingram M et al. Nitric oxide, anti-inflammatory drugs on renal prostaglandins and cyclooxygenase-2. Hypertension 2002; 39: 785-789</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Weicher W, Paliege A, Provoost AP. Upregulation of juxtaglomerular NOS1 and COX-2 preceeds glomerulosklerosis in fown-hooded hypertensive rats. Am J Physiol Renal Physiol 2001; 280: 706-714</mixed-citation><mixed-citation xml:lang="en">Weicher W, Paliege A, Provoost AP. Upregulation of juxtaglomerular NOS1 and COX-2 preceeds glomerulosklerosis in fown-hooded hypertensive rats. Am J Physiol Renal Physiol 2001; 280: 706-714</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Asano K, Taniguchi S, Nakao A et al. Distribution of platelet activating protein receptor mRNA along the rat nephron segments. Biochem Biophys Res Commun 1996; 225 (2): 352-357</mixed-citation><mixed-citation xml:lang="en">Asano K, Taniguchi S, Nakao A et al. Distribution of platelet activating protein receptor mRNA along the rat nephron segments. Biochem Biophys Res Commun 1996; 225 (2): 352-357</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Chao W, Olson MS. Platelet-activating factor: receptor and signaling transduction. Biochem J 1993; 292: 617-629</mixed-citation><mixed-citation xml:lang="en">Chao W, Olson MS. Platelet-activating factor: receptor and signaling transduction. Biochem J 1993; 292: 617-629</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Kester M, Thomas CP, Wang J. Platelet activating factor stimulates multiple signaling pathways in cultured rat mesangial cells. J Cell Physiol 1992; 153 (2): 244-255</mixed-citation><mixed-citation xml:lang="en">Kester M, Thomas CP, Wang J. Platelet activating factor stimulates multiple signaling pathways in cultured rat mesangial cells. J Cell Physiol 1992; 153 (2): 244-255</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Harris RC. Cyclooxygenase-2 inhibition and renal physiology. Am J Cardiol 2002; 89: 10-17</mixed-citation><mixed-citation xml:lang="en">Harris RC. Cyclooxygenase-2 inhibition and renal physiology. Am J Cardiol 2002; 89: 10-17</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Castrop H, Vitzthum H, Schumacher K et al. Low tonicity mediates a downregulation of COX-1 expression in the rat renal papilla. J Am Soc Nephrol 2002; 13: 1136-1144</mixed-citation><mixed-citation xml:lang="en">Castrop H, Vitzthum H, Schumacher K et al. Low tonicity mediates a downregulation of COX-1 expression in the rat renal papilla. J Am Soc Nephrol 2002; 13: 1136-1144</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Fuson AL, Komlosi P, Unlap TM. Immunolocalization of a microsomal prostaglandin E synthase in rabbit kidney. Am J Physiol Renal Physiol 2003; 285: F558-F564</mixed-citation><mixed-citation xml:lang="en">Fuson AL, Komlosi P, Unlap TM. Immunolocalization of a microsomal prostaglandin E synthase in rabbit kidney. Am J Physiol Renal Physiol 2003; 285: F558-F564</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Nishimura K, Tsumagari H, Morioka A et al. Regulation of apoptosis through arachidonate cascade in mammalian cells. Appl Biochem Biotechnol 2002: 102-103 (1-6): 239-250</mixed-citation><mixed-citation xml:lang="en">Nishimura K, Tsumagari H, Morioka A et al. Regulation of apoptosis through arachidonate cascade in mammalian cells. Appl Biochem Biotechnol 2002: 102-103 (1-6): 239-250</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Alexander LD, Alagarsamy S. Cyclic stretch induced cPLA2 and ERK 1/2 signaling in rabbit proximal tubule. Kidney Int 2004; 65 (2): 551-558</mixed-citation><mixed-citation xml:lang="en">Alexander LD, Alagarsamy S. Cyclic stretch induced cPLA2 and ERK 1/2 signaling in rabbit proximal tubule. Kidney Int 2004; 65 (2): 551-558</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Han HJ, Park SH, Lee YJ. Epidermal growth factor effects in primary cultured renal proximal tubule cells: involvement of cAMP, PKC and PLA2. Kidney Blood Press Res 2003; 26 (3): 155-164</mixed-citation><mixed-citation xml:lang="en">Han HJ, Park SH, Lee YJ. Epidermal growth factor effects in primary cultured renal proximal tubule cells: involvement of cAMP, PKC and PLA2. Kidney Blood Press Res 2003; 26 (3): 155-164</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Kaergel E, Muller DN, Honek H. P450-dependent arachidonic acid metabolism and angiotensin-II-induced renal damage. Hypertension 2002; 40: 273-279</mixed-citation><mixed-citation xml:lang="en">Kaergel E, Muller DN, Honek H. P450-dependent arachidonic acid metabolism and angiotensin-II-induced renal damage. Hypertension 2002; 40: 273-279</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Node K, Huo Y, Ruan X. Anti-inflammatory properties of cytochrome p450 epoxygenase-derived eicosanoids. Science 1999; 285: 1276-1279</mixed-citation><mixed-citation xml:lang="en">Node K, Huo Y, Ruan X. Anti-inflammatory properties of cytochrome p450 epoxygenase-derived eicosanoids. Science 1999; 285: 1276-1279</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Spector AA, Fang X, Snyder GD. Epoxyeicosatrienoic acids: metabolism and biochemical function. Prog Lipid Res 2004; 43 (1): 55-90</mixed-citation><mixed-citation xml:lang="en">Spector AA, Fang X, Snyder GD. Epoxyeicosatrienoic acids: metabolism and biochemical function. Prog Lipid Res 2004; 43 (1): 55-90</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Caron N, Hajjam A, Decleves AE. Changes in renal hemodynamics induced by indomethacin in the rat involve cytochrome P450 arachidonic acid-dependent epoxygenases. Clin Exp Pharmacol Physiol 2004; 31 (10): 683-690</mixed-citation><mixed-citation xml:lang="en">Caron N, Hajjam A, Decleves AE. Changes in renal hemodynamics induced by indomethacin in the rat involve cytochrome P450 arachidonic acid-dependent epoxygenases. Clin Exp Pharmacol Physiol 2004; 31 (10): 683-690</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Stec DE, Flasch A, Roman RJ. Distribution of cytochrome P450 isoforms along the nephron in mice. Am J Physiol Renal Physiol 2003; 284 (1): F95-F102</mixed-citation><mixed-citation xml:lang="en">Stec DE, Flasch A, Roman RJ. Distribution of cytochrome P450 isoforms along the nephron in mice. Am J Physiol Renal Physiol 2003; 284 (1): F95-F102</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Ruggenenti P, Schieppati A, Remuzzi G. Progression, remission, regression of chronic renal diseases. Lancet 2001; 357: 1601-1608</mixed-citation><mixed-citation xml:lang="en">Ruggenenti P, Schieppati A, Remuzzi G. Progression, remission, regression of chronic renal diseases. Lancet 2001; 357: 1601-1608</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">Oyekan AO. Differential effects of 20-HETE on intrarenal blood flow in the rat. J Pharmacol Exp Ther 2005; 313 (3): 1289-1295</mixed-citation><mixed-citation xml:lang="en">Oyekan AO. Differential effects of 20-HETE on intrarenal blood flow in the rat. J Pharmacol Exp Ther 2005; 313 (3): 1289-1295</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">Yu Z, Davis BB, Morriseau C et al. Vascular location of soluble epoxide hydrolase in the human kidney. Am J Physiol Renal Physiol 2004; 286 (4): F720-726</mixed-citation><mixed-citation xml:lang="en">Yu Z, Davis BB, Morriseau C et al. Vascular location of soluble epoxide hydrolase in the human kidney. Am J Physiol Renal Physiol 2004; 286 (4): F720-726</mixed-citation></citation-alternatives></ref><ref id="cit44"><label>44</label><citation-alternatives><mixed-citation xml:lang="ru">Alonso-Galicia M, Maier KG, Green AS. Role of 20-HETE in the renal actions of angiotensin II. Am J Physiol Renal Physiol 2002; 283 (1): R60-68</mixed-citation><mixed-citation xml:lang="en">Alonso-Galicia M, Maier KG, Green AS. Role of 20-HETE in the renal actions of angiotensin II. Am J Physiol Renal Physiol 2002; 283 (1): R60-68</mixed-citation></citation-alternatives></ref><ref id="cit45"><label>45</label><citation-alternatives><mixed-citation xml:lang="ru">McCarthy ET, Sharma R, Sharma M. Protective effect of 20-HETE on glomerular protein permeability barrier. Kidney Int 2005; 67 (1): 152-163</mixed-citation><mixed-citation xml:lang="en">McCarthy ET, Sharma R, Sharma M. Protective effect of 20-HETE on glomerular protein permeability barrier. Kidney Int 2005; 67 (1): 152-163</mixed-citation></citation-alternatives></ref><ref id="cit46"><label>46</label><citation-alternatives><mixed-citation xml:lang="ru">Oyekan AO. Nitric oxide inhibits renal cytochrome P450-dependent epoxygenases in the rat. Clin Exp Pharmacol Physiol 2002; 29 (11): 990-995</mixed-citation><mixed-citation xml:lang="en">Oyekan AO. Nitric oxide inhibits renal cytochrome P450-dependent epoxygenases in the rat. Clin Exp Pharmacol Physiol 2002; 29 (11): 990-995</mixed-citation></citation-alternatives></ref><ref id="cit47"><label>47</label><citation-alternatives><mixed-citation xml:lang="ru">Hoagland KM, Flasch AK, Roman RJ. Inhibition of 20-HETE formation promote salt-sensitive hypertension in rats. Hypertension 2003; 42 (4): 669-673</mixed-citation><mixed-citation xml:lang="en">Hoagland KM, Flasch AK, Roman RJ. Inhibition of 20-HETE formation promote salt-sensitive hypertension in rats. Hypertension 2003; 42 (4): 669-673</mixed-citation></citation-alternatives></ref><ref id="cit48"><label>48</label><citation-alternatives><mixed-citation xml:lang="ru">Winokur TS, Morrison AR. Regional synthesis of monohydroxy eikosanoids by the kidney. J Biol Chem 1981; 256: 10221-10223</mixed-citation><mixed-citation xml:lang="en">Winokur TS, Morrison AR. Regional synthesis of monohydroxy eikosanoids by the kidney. J Biol Chem 1981; 256: 10221-10223</mixed-citation></citation-alternatives></ref><ref id="cit49"><label>49</label><citation-alternatives><mixed-citation xml:lang="ru">Henderson WR. The role of leukotrienes in inflammation. Ann Int Med 1994; 121 (9): 684-697</mixed-citation><mixed-citation xml:lang="en">Henderson WR. The role of leukotrienes in inflammation. Ann Int Med 1994; 121 (9): 684-697</mixed-citation></citation-alternatives></ref><ref id="cit50"><label>50</label><citation-alternatives><mixed-citation xml:lang="ru">Абрамова ТВ. Нейтрофилы при гломерулонефрите Нефрология 2005; 9 (2): 9-16</mixed-citation><mixed-citation xml:lang="en">Абрамова ТВ. Нейтрофилы при гломерулонефрите Нефрология 2005; 9 (2): 9-16</mixed-citation></citation-alternatives></ref><ref id="cit51"><label>51</label><citation-alternatives><mixed-citation xml:lang="ru">Montero A, Uda S, Kelavkar U. Increased 5-lipoxygenase activating protein in immune-mediated experimental nephritis. J Nephrol 2003; 16 (5): 686-690</mixed-citation><mixed-citation xml:lang="en">Montero A, Uda S, Kelavkar U. Increased 5-lipoxygenase activating protein in immune-mediated experimental nephritis. J Nephrol 2003; 16 (5): 686-690</mixed-citation></citation-alternatives></ref><ref id="cit52"><label>52</label><citation-alternatives><mixed-citation xml:lang="ru">Brock TG. Regulating leukotriene synthesis: the role of nuclear 5-lipoxigenase. J Cell Biochem 2005; 126 (2): 138-142</mixed-citation><mixed-citation xml:lang="en">Brock TG. Regulating leukotriene synthesis: the role of nuclear 5-lipoxigenase. J Cell Biochem 2005; 126 (2): 138-142</mixed-citation></citation-alternatives></ref><ref id="cit53"><label>53</label><citation-alternatives><mixed-citation xml:lang="ru">Valdivielso JM, Montero A, Bard KF. Inhibition of 5-lipoxygenase activating protein decreases proteinuria in diabetic rats. J Nephrol 2003; 16 (1): 85-94</mixed-citation><mixed-citation xml:lang="en">Valdivielso JM, Montero A, Bard KF. Inhibition of 5-lipoxygenase activating protein decreases proteinuria in diabetic rats. J Nephrol 2003; 16 (1): 85-94</mixed-citation></citation-alternatives></ref><ref id="cit54"><label>54</label><citation-alternatives><mixed-citation xml:lang="ru">Daha MR, van Kooten C. Is proximal tubular cell a proinflammatory cell? Nephrol Dialys Transplant 2000; 15 [Suppl. 6]: 41-43</mixed-citation><mixed-citation xml:lang="en">Daha MR, van Kooten C. Is proximal tubular cell a proinflammatory cell? Nephrol Dialys Transplant 2000; 15 [Suppl. 6]: 41-43</mixed-citation></citation-alternatives></ref><ref id="cit55"><label>55</label><citation-alternatives><mixed-citation xml:lang="ru">Patel NS, Cuzzocrea S, Chatterjee PK. Reduction of renal ischemia-reperfusion injury in 5-lipoxygenase knockout mice and by the 5-lipoxygenase inhibitor zileuton. Mol Pharmacol 2004; 66 (2): 220-227</mixed-citation><mixed-citation xml:lang="en">Patel NS, Cuzzocrea S, Chatterjee PK. Reduction of renal ischemia-reperfusion injury in 5-lipoxygenase knockout mice and by the 5-lipoxygenase inhibitor zileuton. Mol Pharmacol 2004; 66 (2): 220-227</mixed-citation></citation-alternatives></ref><ref id="cit56"><label>56</label><citation-alternatives><mixed-citation xml:lang="ru">Sener G, Kaabsakal L, Cetinel S. Leukotriene receptor blocker montelukast protects against burn-induced oxidative injury of the skin and remote organs. Burns 2005; 31 (5): 587-596</mixed-citation><mixed-citation xml:lang="en">Sener G, Kaabsakal L, Cetinel S. Leukotriene receptor blocker montelukast protects against burn-induced oxidative injury of the skin and remote organs. Burns 2005; 31 (5): 587-596</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
